These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis. Prescott WA; Nagel JL Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477 [TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the ototoxic action of aminoglycoside antibiotics (A.A.) on the inner ear by high frequency audiometry (HRA)]. Popielski L Otolaryngol Pol; 2003; 57(3):461-3. PubMed ID: 14677559 [No Abstract] [Full Text] [Related]
5. National survey of extended-interval aminoglycoside dosing. Chuck SK; Raber SR; Rodvold KA; Areff D Clin Infect Dis; 2000 Mar; 30(3):433-9. PubMed ID: 10722424 [TBL] [Abstract][Full Text] [Related]
6. Parenteral aminoglycoside antibiotics--1977. Clinical use. Simberkoff MS; Rahal JJ N Y State J Med; 1977 Jan; 77(1):81-5. PubMed ID: 401973 [No Abstract] [Full Text] [Related]
7. The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients. Mueller EW; Boucher BA Surg Infect (Larchmt); 2009 Dec; 10(6):563-70. PubMed ID: 20035611 [TBL] [Abstract][Full Text] [Related]
8. Extended-interval aminoglycosides in children: more guidance is needed. Best EJ; Palasanthiran P; Gazarian M Pediatrics; 2005 Mar; 115(3):827-8; author reply 828. PubMed ID: 15741401 [No Abstract] [Full Text] [Related]
9. [Which partner for the betalactam agent in empirical combined therapy? II. Aminoglycoside]. Mimoz O; Grollier G Ann Fr Anesth Reanim; 2004 Jun; 23(6):639-42. PubMed ID: 15234735 [No Abstract] [Full Text] [Related]
10. Aminoglycoside dosing in patients by kidney function and area under the curve: the Sawchuk-Zaske dosing method revisited in the era of obesity. Pai MP; Rodvold KA Diagn Microbiol Infect Dis; 2014 Feb; 78(2):178-87. PubMed ID: 24268292 [TBL] [Abstract][Full Text] [Related]
11. [Pharmacodynamics of tobramycin in the infant and the child]. Bégué P; Laplane R Nouv Presse Med; 1974 Apr; 3(0):64-6. PubMed ID: 4600777 [No Abstract] [Full Text] [Related]
12. Telavancin (Vibativ) for gram-positive skin infections. Med Lett Drugs Ther; 2010 Jan; 52(1329):1-2. PubMed ID: 20208468 [No Abstract] [Full Text] [Related]
13. New dosing strategies for antibacterial agents in the neonate. de Hoog M; Mouton JW; van den Anker JN Semin Fetal Neonatal Med; 2005 Apr; 10(2):185-94. PubMed ID: 15701583 [TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology of aminoglycoside antibiotics in pediatrics. Blumer JL; Reed MD Pediatr Clin North Am; 1983 Feb; 30(1):195-208. PubMed ID: 6338465 [No Abstract] [Full Text] [Related]
16. Use of aminoglycosides in preterm neonates: a simple task? van den Anker J J Pediatr; 2009 Jun; 154(6):935. PubMed ID: 19446105 [No Abstract] [Full Text] [Related]
17. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis. Graham AC; Mercier RC; Achusim LE; Pai MP Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688 [TBL] [Abstract][Full Text] [Related]
18. [Sensitization to antibiotics of the aminoglycoside group]. Van Joost T; Boelen RE; Faber WR Ned Tijdschr Geneeskd; 1981 Apr; 125(15):572-5. PubMed ID: 6454079 [No Abstract] [Full Text] [Related]
19. [Pathomorphological aspects of the action of aminoglycoside antibiotics on the acoustic analyzer]. Zhuravskiĭ SG; Tomson VV; Tsvyleva ID; Ivanov AG Vestn Otorinolaringol; 2003; (2):55-60. PubMed ID: 12958868 [No Abstract] [Full Text] [Related]
20. Therapeutic drug monitoring of aminoglycosides in neonates. Touw DJ; Westerman EM; Sprij AJ Clin Pharmacokinet; 2009; 48(2):71-88. PubMed ID: 19271781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]